Brief: Cannara Biotech Reports Q4 And 2022 Fiscal Year Financial Results
25/11/2022 13:05
Nov 25 (Reuters) - Cannara Biotech Inc LOVE.V :
* CANNARA BIOTECH INC. REPORTS RECORD Q4 AND 2022 FISCAL
YEAR
FINANCIAL RESULTS
* CANNARA BIOTECH INC Q4 REVENUE ROSE 84 PERCENT TO C$12.0
MILLION
* CANNARA BIOTECH INC - QTRLY EARNINGS PER SHARE $0.01
Source text for Eikon: ID:nCNWfpyBKa
Further company coverage: LOVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04